NM_024537.4:c.647G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_024537.4(CARS2):​c.647G>A​(p.Gly216Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0182 in 1,600,186 control chromosomes in the GnomAD database, including 373 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G216R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.016 ( 30 hom., cov: 33)
Exomes 𝑓: 0.018 ( 343 hom. )

Consequence

CARS2
NM_024537.4 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.03

Publications

8 publications found
Variant links:
Genes affected
CARS2 (HGNC:25695): (cysteinyl-tRNA synthetase 2, mitochondrial) This gene encodes a putative member of the class I family of aminoacyl-tRNA synthetases. These enzymes play a critical role in protein biosynthesis by charging tRNAs with their cognate amino acids. This protein is encoded by the nuclear genome but is likely to be imported to the mitochondrion where it is thought to catalyze the ligation of cysteine to tRNA molecules. A splice-site mutation in this gene has been associated with a novel progressive myoclonic epilepsy disease with similar symptoms to MERRF syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2017]
CARS2 Gene-Disease associations (from GenCC):
  • combined oxidative phosphorylation defect type 27
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Laboratory for Molecular Medicine, G2P
  • mitochondrial disease
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00331226).
BP6
Variant 13-110683059-C-T is Benign according to our data. Variant chr13-110683059-C-T is described in ClinVar as Benign. ClinVar VariationId is 380445.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0159 (2424/152302) while in subpopulation AMR AF = 0.0309 (472/15294). AF 95% confidence interval is 0.0286. There are 30 homozygotes in GnomAd4. There are 1261 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 30 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CARS2NM_024537.4 linkc.647G>A p.Gly216Glu missense_variant Exon 6 of 15 ENST00000257347.9 NP_078813.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CARS2ENST00000257347.9 linkc.647G>A p.Gly216Glu missense_variant Exon 6 of 15 1 NM_024537.4 ENSP00000257347.4

Frequencies

GnomAD3 genomes
AF:
0.0159
AC:
2425
AN:
152184
Hom.:
30
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00369
Gnomad AMI
AF:
0.0231
Gnomad AMR
AF:
0.0308
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.0151
Gnomad FIN
AF:
0.0339
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0192
Gnomad OTH
AF:
0.0158
GnomAD2 exomes
AF:
0.0196
AC:
4692
AN:
239186
AF XY:
0.0194
show subpopulations
Gnomad AFR exome
AF:
0.00293
Gnomad AMR exome
AF:
0.0368
Gnomad ASJ exome
AF:
0.00193
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0363
Gnomad NFE exome
AF:
0.0189
Gnomad OTH exome
AF:
0.0166
GnomAD4 exome
AF:
0.0185
AC:
26762
AN:
1447884
Hom.:
343
Cov.:
30
AF XY:
0.0184
AC XY:
13221
AN XY:
720240
show subpopulations
African (AFR)
AF:
0.00274
AC:
89
AN:
32468
American (AMR)
AF:
0.0363
AC:
1537
AN:
42344
Ashkenazi Jewish (ASJ)
AF:
0.00162
AC:
42
AN:
25898
East Asian (EAS)
AF:
0.0000260
AC:
1
AN:
38466
South Asian (SAS)
AF:
0.0189
AC:
1593
AN:
84254
European-Finnish (FIN)
AF:
0.0341
AC:
1811
AN:
53036
Middle Eastern (MID)
AF:
0.00609
AC:
27
AN:
4436
European-Non Finnish (NFE)
AF:
0.0187
AC:
20679
AN:
1107260
Other (OTH)
AF:
0.0165
AC:
983
AN:
59722
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
1140
2280
3420
4560
5700
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
772
1544
2316
3088
3860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0159
AC:
2424
AN:
152302
Hom.:
30
Cov.:
33
AF XY:
0.0169
AC XY:
1261
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.00368
AC:
153
AN:
41572
American (AMR)
AF:
0.0309
AC:
472
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5186
South Asian (SAS)
AF:
0.0151
AC:
73
AN:
4834
European-Finnish (FIN)
AF:
0.0339
AC:
360
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0192
AC:
1305
AN:
68020
Other (OTH)
AF:
0.0156
AC:
33
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
128
256
385
513
641
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0170
Hom.:
88
Bravo
AF:
0.0154
TwinsUK
AF:
0.0175
AC:
65
ALSPAC
AF:
0.0213
AC:
82
ESP6500AA
AF:
0.00227
AC:
10
ESP6500EA
AF:
0.0195
AC:
168
ExAC
AF:
0.0185
AC:
2250
Asia WGS
AF:
0.00491
AC:
17
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 14, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Combined oxidative phosphorylation defect type 27 Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.71
T
BayesDel_noAF
Benign
-0.76
CADD
Benign
2.0
DANN
Benign
0.38
DEOGEN2
Benign
0.16
T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.055
N
LIST_S2
Benign
0.58
T
MetaRNN
Benign
0.0033
T
MetaSVM
Benign
-0.97
T
MutationAssessor
Uncertain
2.1
M
PhyloP100
-1.0
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-1.4
N
REVEL
Benign
0.060
Sift
Benign
0.40
T
Sift4G
Benign
0.59
T
Polyphen
0.0050
B
Vest4
0.046
MPC
0.24
ClinPred
0.00098
T
GERP RS
-4.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.035
gMVP
0.63
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146773721; hg19: chr13-111335406; COSMIC: COSV106085398; COSMIC: COSV106085398; API